ADJUVANT BASED ON HIV TAT AND USES THEREOF

摘要

The invention provides a tat adjuvant, comprising: (a) a plasmid containing the nucleic acid sequence encoding HIV Tat, a fragment thereof or a variant thereof; or (b) HIV Tat, a fragment thereof or a variant thereof. The invention also provides a vaccine composition which includes a Tat adjuvant, wherein the tat adjuvant can increase the immune response elicited by the vaccine.